AR127022A1 - Adaptación de hospedadores de plataforma a medios igf - Google Patents

Adaptación de hospedadores de plataforma a medios igf

Info

Publication number
AR127022A1
AR127022A1 ARP220102449A ARP220102449A AR127022A1 AR 127022 A1 AR127022 A1 AR 127022A1 AR P220102449 A ARP220102449 A AR P220102449A AR P220102449 A ARP220102449 A AR P220102449A AR 127022 A1 AR127022 A1 AR 127022A1
Authority
AR
Argentina
Prior art keywords
igf
interest
protein
cell
mammalian
Prior art date
Application number
ARP220102449A
Other languages
English (en)
Spanish (es)
Inventor
Kristine Marie Daris
Huong Thi Ngoc Le
Eric Gislason
Trent Phillip Munro
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR127022A1 publication Critical patent/AR127022A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/105Insulin-like growth factors [IGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ARP220102449A 2021-09-10 2022-09-09 Adaptación de hospedadores de plataforma a medios igf AR127022A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163242623P 2021-09-10 2021-09-10

Publications (1)

Publication Number Publication Date
AR127022A1 true AR127022A1 (es) 2023-12-13

Family

ID=84053053

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220102449A AR127022A1 (es) 2021-09-10 2022-09-09 Adaptación de hospedadores de plataforma a medios igf

Country Status (13)

Country Link
US (1) US20230082811A1 (https=)
EP (1) EP4399225A1 (https=)
JP (1) JP2024533319A (https=)
KR (1) KR20240054986A (https=)
CN (1) CN117897401A (https=)
AR (1) AR127022A1 (https=)
AU (1) AU2022344262A1 (https=)
CA (1) CA3230418A1 (https=)
CL (1) CL2024000698A1 (https=)
IL (1) IL310660A (https=)
MX (1) MX2024002959A (https=)
TW (1) TW202328442A (https=)
WO (1) WO2023039502A1 (https=)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
US6319494B1 (en) 1990-12-14 2001-11-20 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化b−b10
US5262308A (en) * 1992-01-28 1993-11-16 Thomas Jefferson University Cell lines which constitutively express IGF-1 and IGF-1 R
IL104570A0 (en) 1992-03-18 1993-05-13 Yeda Res & Dev Chimeric genes and cells transformed therewith
ES2227669T3 (es) 1996-01-11 2005-04-01 Immunex Corporation Elementos de secuencia que aumentan la expresion (ease) para sistemas de expresion de eurocariotas.
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
GB9928787D0 (en) 1999-12-03 2000-02-02 Medical Res Council Direct screening method
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
GB0025144D0 (en) 2000-10-13 2000-11-29 Medical Res Council Concatenated nucleic acid sequences
US20040202995A1 (en) 2003-04-09 2004-10-14 Domantis Nucleic acids, proteins, and screening methods
EP1614755A1 (en) 2004-07-07 2006-01-11 ARTEMIS Pharmaceuticals GmbH Target transgenesis of short hairpin RNA expression cassette using recombinase mediated cassette exchange
US8053238B2 (en) 2005-10-31 2011-11-08 Unhwa Corporation Isolated population of plant single cells and method of preparing the same
US20070231895A1 (en) * 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
AU2007294731B2 (en) * 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
WO2008154014A2 (en) 2007-06-11 2008-12-18 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
SG191561A1 (en) 2008-08-22 2013-07-31 Sangamo Biosciences Inc Methods and compositions for targeted single-stranded cleavage and targeted integration
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
JP6195191B2 (ja) 2013-08-08 2017-09-13 極東製薬工業株式会社 無タンパク質・無脂質培地馴化細胞株を用いた組換えタンパク質の製造方法
US10973069B2 (en) 2017-08-07 2021-04-06 Lg Electronics Inc. Method and apparatus for keeping DC configuration
EP3441471A1 (en) * 2017-08-08 2019-02-13 CEVEC Pharmaceuticals GmbH Use of constitutively active variants of growth factor receptors as selection makers for the generation of stable producer cell lines

Also Published As

Publication number Publication date
AU2022344262A1 (en) 2024-02-22
CN117897401A (zh) 2024-04-16
IL310660A (en) 2024-04-01
CA3230418A1 (en) 2023-03-16
US20230082811A1 (en) 2023-03-16
CL2024000698A1 (es) 2024-09-06
JP2024533319A (ja) 2024-09-12
KR20240054986A (ko) 2024-04-26
WO2023039502A1 (en) 2023-03-16
TW202328442A (zh) 2023-07-16
MX2024002959A (es) 2024-03-27
EP4399225A1 (en) 2024-07-17

Similar Documents

Publication Publication Date Title
JP2019201661A5 (https=)
JP2024009934A5 (https=)
JP2016105737A5 (https=)
JP2015521848A5 (https=)
Wong et al. From chemostats to high‐density perfusion: the progression of continuous mammalian cell cultivation
CN116716348A (zh) 一种提高重组细胞的蛋白表达量的方法
MX2023005003A (es) Celulas huespedes recombinantes para producir acido antranilico.
EP4368699A3 (en) Methods of producing recombinant proteins
CN106282090B (zh) 一种驯化后的cho-s细胞系及其培养方法与应用
AR127022A1 (es) Adaptación de hospedadores de plataforma a medios igf
CN106916775B (zh) 高产纳米多聚磷酸体的转基因藻株及其制备方法
CN104152402A (zh) 一种半滑舌鳎伪雄鱼性腺细胞系的构建与应用方法
CN104099371A (zh) Kap26.1基因作为引入绒山羊细胞改善绒毛细度的外源基因的应用
WO2023195367A1 (ja) シアノバクテリアの外膜剥離の判定方法、シアノバクテリアの外膜剥離の判定装置、及び、プログラム
Mertz New Vaccine-Manufacturing Methods Are Moving Away From the Egg
MX2023001270A (es) Proceso de fermentacion industrial para bacillus mediante el uso de recoleccion parcial.
JP2017070252A (ja) 有機酸の製造方法
CN116042666B (zh) 过表达基因galK、galT及其工程菌
CN115895918B (zh) 一种裂解性多糖单加氧酶及其应用
CN111893130A (zh) 一种pcci-2u质粒及其构建方法和应用
JP6499587B2 (ja) 形質転換体およびその製造方法、ならびに乳酸の製造方法
US20250304954A1 (en) Nucleic acid construct
CN110093404A (zh) 应用荧光实时定量pcr筛选重组汉逊酵母病毒样颗粒表达株的方法
CN117778501A (zh) 目的蛋白的生产方法和稳转细胞株的优化方法
CN120718968A (zh) 一种生物合成丁酮醇的方法